Eric P F Chow Selected Research

Pristinamycin

1/2020	Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium.
1/2018	Clinical Characteristics of Anorectal Mycoplasma genitalium Infection and Microbial Cure in Men Who Have Sex With Men.
1/2018	Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric P F Chow Research Topics

Disease

18	Infections 09/2022 - 12/2012
11	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2022 - 11/2018
9	Gonorrhea 01/2022 - 02/2015
7	Syphilis 06/2022 - 01/2017
4	Condylomata Acuminata (Genital Wart) 12/2021 - 05/2015
4	Urethritis 01/2021 - 02/2017
4	HIV Infections (HIV Infection) 10/2019 - 04/2012
2	primary Syphilis 01/2022 - 11/2020
2	Nausea 01/2022 - 01/2021
2	Vomiting 01/2022 - 01/2021
2	Bacterial Vaginosis 01/2022 - 10/2021
2	Chlamydia Infections 01/2021 - 01/2018
2	Hepatitis A (Hepatitis, Infectious) 01/2020 - 01/2020
2	Proctitis 01/2019 - 01/2018
2	Lymphogranuloma Venereum 01/2017 - 10/2016
1	Vulvovaginal Candidiasis 01/2022
1	COVID-19 12/2021
1	Papillomavirus Infections 09/2021
1	Pruritus (Itching) 09/2021
1	secondary Syphilis 01/2021
1	Candidiasis (Moniliasis) 01/2021
1	Diarrhea 01/2021
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2020
1	Vaginal Discharge 01/2020
1	Suppuration 01/2020
1	Uterine Cervicitis (Cervicitis) 01/2019
1	Reinfection 01/2019
1	Warts (Wart) 01/2018
1	Disease Progression 06/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2015
1	Coinfection 06/2012

Drug/Important Bio-Agent (IBA)

8	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 01/2017
6	MacrolidesIBA 09/2022 - 02/2017
6	Doxycycline (Periostat)FDA LinkGeneric 01/2021 - 10/2016
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2016
4	Moxifloxacin (Avelox)FDA Link 09/2022 - 01/2018
4	VaccinesIBA 12/2021 - 01/2019
4	Pharmaceutical PreparationsIBA 01/2018 - 12/2012
3	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022 - 01/2019
3	PristinamycinIBA 01/2020 - 01/2018
3	LubricantsIBA 01/2019 - 10/2016
2	Indicators and Reagents (Reagents)IBA 06/2022 - 01/2018
2	ReaginsIBA 06/2022 - 01/2021
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 01/2021
2	Combined VaccinesIBA 10/2021 - 01/2019
2	sitafloxacinIBA 12/2020 - 01/2019
2	Nucleic AcidsIBA 01/2020 - 01/2017
2	Biological ProductsIBA 11/2018 - 01/2017
2	ORALIT (ORS)IBA 01/2018 - 05/2015
2	Bacterial DNAIBA 11/2017 - 10/2016
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2012 - 06/2012
1	AntibodiesIBA 01/2022
1	MouthwashesIBA 01/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2022
1	16S Ribosomal RNAIBA 10/2021
1	Imiquimod (Aldara)FDA LinkGeneric 09/2021
1	ElementsIBA 10/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Green OrIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2018
1	mesoglycanIBA 01/2016
1	antibiotic K 4 (K 4)IBA 12/2012
1	Methadone (Dolophine)FDA LinkGeneric 12/2012

Therapy/Procedure

9	Condoms (Condom) 01/2022 - 04/2012
4	Therapeutics 12/2021 - 01/2019
2	Ambulatory Care (Outpatient Care) 01/2021 - 10/2019
1	Self-Testing 01/2022
1	Art Therapy 12/2021
1	Aftercare (After-Treatment) 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 06/2015